Lung Cancer Update cover image

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Immunotherapy and Other Nontargeted Approaches for Lung Cancer

Lung Cancer Update

00:00

Tusa-Mitumab Ref Tansin: A Targeted Antibody Drug Conjugate

Luis: Dothi-Taxel is like the chloroambusil of lung cancer. Everybody wants to beat it up, but not too many people have actually. What about this other antibody drug conjugate, Heather? I'm just going to say Tusa. It's a little tricky to pronounce,. Can you explain what it is and how it relates to CEA, how it works? Luis: This is the Tusa-Mitumab ref tansin, so different payload, and that's important when we think about toxicity. With higher C-cam levels, there seems to be a higher correlation with response.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app